271 related articles for article (PubMed ID: 17727794)
1. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin.
Hugnet C; Lespine A; Alvinerie M
J Pharm Pharm Sci; 2007; 10(3):311-8. PubMed ID: 17727794
[TBL] [Abstract][Full Text] [Related]
2. Ketoconazole increases the plasma levels of ivermectin in sheep.
Alvinerie M; Dupuy J; Kiki-Mvouaka S; Sutra JF; Lespine A
Vet Parasitol; 2008 Oct; 157(1-2):117-22. PubMed ID: 18657366
[TBL] [Abstract][Full Text] [Related]
3. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition.
Ballent M; Lifschitz A; Virkel G; Sallovitz J; Lanusse C
J Vet Pharmacol Ther; 2007 Jun; 30(3):242-8. PubMed ID: 17472656
[TBL] [Abstract][Full Text] [Related]
4. Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs.
Kuroha M; Shirai Y; Shimoda M
J Vet Pharmacol Ther; 2004 Oct; 27(5):355-9. PubMed ID: 15500574
[TBL] [Abstract][Full Text] [Related]
5. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of some injectable preparations containing ivermectin in dogs.
Eraslan G; Kanbur M; Liman BC; Cam Y; Karabacak M; Altinordulu S
Food Chem Toxicol; 2010; 48(8-9):2181-5. PubMed ID: 20488222
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ivermectin in pregnant and nonpregnant sheep.
Pérez R; Palma C; Núñez MJ; Cox J; Arboix M
J Vet Pharmacol Ther; 2008 Feb; 31(1):71-6. PubMed ID: 18177322
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of ketoconazole and its effects on the pharmacokinetics of midazolam and fentanyl in dogs.
KuKanich B; Hubin M
J Vet Pharmacol Ther; 2010 Feb; 33(1):42-9. PubMed ID: 20444024
[TBL] [Abstract][Full Text] [Related]
9. Reduction of the inhibitory effect of ketoconazole on budesonide pharmacokinetics by separation of their time of administration.
Seidegård J
Clin Pharmacol Ther; 2000 Jul; 68(1):13-7. PubMed ID: 10945311
[TBL] [Abstract][Full Text] [Related]
10. Sex-related differences in the gastrointestinal disposition of ivermectin in the rat: P-glycoprotein involvement and itraconazole modulation.
Lifschitz A; Ballent M; Virkel G; Sallovitz J; Lanusse C
J Pharm Pharmacol; 2006 Aug; 58(8):1055-62. PubMed ID: 16872551
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interaction of the antiparasitic agents ivermectin and spinosad in dogs.
Dunn ST; Hedges L; Sampson KE; Lai Y; Mahabir S; Balogh L; Locuson CW
Drug Metab Dispos; 2011 May; 39(5):789-95. PubMed ID: 21321059
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs.
Al-Azzam SI; Fleckenstein L; Cheng KJ; Dzimianski MT; McCall JW
Biopharm Drug Dispos; 2007 Nov; 28(8):431-8. PubMed ID: 17847063
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep.
Pérez R; Palma C; Núñez MJ; Cox J
J Vet Pharmacol Ther; 2008 Oct; 31(5):406-14. PubMed ID: 19000259
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer.
Yong WP; Desai AA; Innocenti F; Ramirez J; Shepard D; Kobayashi K; House L; Fleming GF; Vogelzang NJ; Schilsky RL; Ratain MJ
Cancer Chemother Pharmacol; 2007 Nov; 60(6):811-9. PubMed ID: 17308893
[TBL] [Abstract][Full Text] [Related]
15. The need for multiple doses of 400 mg ketoconazole as a precipitant inhibitor of a CYP3A substrate in an in vivo drug-drug interaction study.
Oo C; Chen YC
J Clin Pharmacol; 2009 Mar; 49(3):368-9; author reply 370. PubMed ID: 19246734
[No Abstract] [Full Text] [Related]
16. Effect of oral ketoconazole on oral and intravenous pharmacokinetics of simvastatin and its acid in cynomolgus monkeys.
Ogasawara A; Utoh M; Nii K; Ueda A; Yoshikawa T; Kume T; Fukuzaki K
Drug Metab Dispos; 2009 Jan; 37(1):122-8. PubMed ID: 18854378
[TBL] [Abstract][Full Text] [Related]
17. Combined subcutaneous administration of ivermectin and nitroxynil in sheep: age/body weight related changes to the kinetic disposition of both compounds.
Moreno L; Ceballos L; Lifschitz A; Bistoletti M; Alvarez L; Lanusse C
Res Vet Sci; 2010 Apr; 88(2):315-20. PubMed ID: 19892381
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys.
Ogasawara A; Kume T; Kazama E
Drug Metab Dispos; 2007 Mar; 35(3):410-8. PubMed ID: 17142564
[TBL] [Abstract][Full Text] [Related]
19. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR
Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938
[TBL] [Abstract][Full Text] [Related]
20. The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus.
Stroh M; Palcza J; McCrea J; Marsilio S; Breidinger S; Panebianco D; Johnson-Levonas A; Kraft WK; Orford K; Murphy G; Agrawal N; Trucksis M; Wagner JA; Iwamoto M
Cancer Chemother Pharmacol; 2012 May; 69(5):1247-53. PubMed ID: 22290273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
